FDA Inspection 991425 — Michigan Medicine

Michigan Medicine — FEI 3003531601

The FDA completed an inspection of Michigan Medicine on June 29, 2016 in Ann Arbor, MI. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 29, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ann Arbor, MI (United States)

Citations

IDCFRDescription
115921 CFR 211.28(a)Clothing appropriate for duties performed
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
143521 CFR 211.42(c)(10)(v)Cleaning System
143621 CFR 211.42(c)(10)(vi)Equipment to control conditions
145121 CFR 211.113(b)Procedures for sterile drug products
186921 CFR 211.94(c)Containers & Closures Clean, Sterilized, Pyrogen-free
193221 CFR 211.167(a)Sterility/pyrogen-free testing
202821 CFR 211.192Extent of discrepancy, failure investigations